Telomeres protect chromosome ends and serve as a substrate for telomerase, a reverse transcriptase that adds DNA repeats to the telomere terminus. In the absence of telomerase, telomeres progressively shorten, ultimately leading to telomere uncapping, a structural change at the telomere that activates DNA damage responses and leads to ligation of chromosome ends. Telomere uncapping has been implicated in aging and cancer, yet the precise mechanism of uncapping and its relationship to cell cycle remain to be defined. Here, we show that telomeres uncap in an S-phase-dependent manner in gastrointestinal progenitors of TERT ؊/؊ mice. We develop an in vivo assay that allows a quantitative kinetic assessment of telomere dysfunction-induced apoptosis and its relationship to cell cycle. By exploiting the mathematical relationship between rates of generation and clearance of apoptotic cells, we show that 86.2 ؎ 8.8% of apoptotic gastrointestinal cells undergo programmed cell death either late in S-phase or in G 2. Apoptosis is primarily triggered via a signaling cascade from newly uncapped telomeres to the tumor suppressor p53, rather than by chromosome fusion-bridge breakage, because mitotic blockade did not alter the rate of newly generated apoptotic bodies. These data support a model in which rapidly dividing progenitor cells within a tissue with short telomeres are vulnerable to telomere uncapping during or shortly after telomere replication.
Telomeres protect chromosome ends and serve as a substrate for telomerase, a reverse transcriptase that adds DNA repeats to the telomere terminus. In the absence of telomerase, telomeres progressively shorten, ultimately leading to telomere uncapping, a structural change at the telomere that activates DNA damage responses and leads to ligation of chromosome ends. Telomere uncapping has been implicated in aging and cancer, yet the precise mechanism of uncapping and its relationship to cell cycle remain to be defined. Here, we show that telomeres uncap in an S-phase-dependent manner in gastrointestinal progenitors of TERT ؊/؊ mice. We develop an in vivo assay that allows a quantitative kinetic assessment of telomere dysfunction-induced apoptosis and its relationship to cell cycle. By exploiting the mathematical relationship between rates of generation and clearance of apoptotic cells, we show that 86.2 ؎ 8.8% of apoptotic gastrointestinal cells undergo programmed cell death either late in S-phase or in G 2. Apoptosis is primarily triggered via a signaling cascade from newly uncapped telomeres to the tumor suppressor p53, rather than by chromosome fusion-bridge breakage, because mitotic blockade did not alter the rate of newly generated apoptotic bodies. These data support a model in which rapidly dividing progenitor cells within a tissue with short telomeres are vulnerable to telomere uncapping during or shortly after telomere replication.
apoptosis ͉ cell cycle ͉ DNA damage ͉ stem cells ͉ telomerase T elomeres are nucleoprotein structures that serve a critical role in maintaining chromosome stability and cell viability (1) . Telomere length is maintained by telomerase, the enzyme that adds telomere repeats. Chromosome ends in mammals comprise double-stranded TTAGGG repeats that terminate in a single stranded 3Ј overhang. This overhang stably invades more proximal telomere sequences to form a t-loop that is highly bound by the shelterin protein complex (2) . In this protected conformation, telomeres suppress DNA damage responses and prevent recombination at chromosome ends. Disruption of telomere conformation through telomere shortening or other means results in telomere dysfunction, a process also termed telomere uncapping (3) . Telomere uncapping triggers either cellular senescence or apoptosis; however, the precise changes that occur at uncapped telomeres and the relationship between telomere uncapping and cell cycle are not well understood.
In human cells with insufficient telomerase, telomeres shorten with each cell division because of the end-replication problem, the inability of DNA polymerase to fully replicate the lagging DNA strand, ultimately leading to replicative senescence as a subset of dysfunctional telomeres recruit DNA damage foci containing phosphorylated histone-2AX and 53BP1 to uncapped chromosome ends (4, 5) . The replicative senescence response depends on p53 and Rb, because inactivation of these pathways enables cells to bypass senescence and to continue proliferating (6) . In this setting of deactivated checkpoints, dysfunctional telomeres are ligated, yielding fused chromosomes that break during a subsequent anaphase when two independent centromeres are pulled to opposite spindle poles (7) . In contrast to the senescence response seen in primary human cells in culture, critically short telomeres in telomerase-deficient mice commonly induce apoptosis, including male germ cells, gastrointestinal cells, and lymphocytes (8) (9) (10) (11) . Senescence in telomerase knockout tissues has also been seen, particularly in regenerating liver (12) , in lymphomas (13) , and in the context of a p53 mutant that lacks the ability to induce apoptosis (14) .
The relationship between cell cycle and telomere uncapping has been most extensively studied in the setting of interference with telomere-binding protein function (2) . Loss of function of the telomere-binding protein TRF2 disrupts the protective telomere protein complex, leading to rapid telomere uncapping, generation of damage foci at chromosome ends, processing of the telomere single-stranded overhang, and covalent ligation to generate fused chromosomes (5, 15, 16) . Impairing TRF2 function can cause telomere uncapping even in quiescent cells in vivo and can lead to chromosomal fusion in both G 1 and G 2 phases of cell cycle (16) (17) (18) (19) . In contrast, the relationship between cell cycle and telomere uncapping in cells whose chromosomes encounter the end-replication problem because of insufficient levels of telomerase remains less well understood.
To understand the relationship between telomere uncapping and cell cycle, we developed a means for studying the kinetics and cell cycle timing of apoptosis triggered by telomere uncapping in gastrointestinal progenitors in mice lacking TERT, the catalytic component of telomerase. By relating the rate of generation and clearance of apoptotic progenitor cells, we determined that apoptosis is tightly coupled to passage through S-phase, indicating that telomeres uncap in late S-phase or G 2 in a stereotyped fashion. These results support a model in which telomere uncapping is coupled to telomere replication as a subset of critically short telomeres signal a DNA damage response.
Results

Apoptosis and p53 Activation in Proliferating Progenitor Cells in
Late-Generation TERT-Deficient Mice. Epithelium of the small intestine is continuously renewed through the division of stem cells and progenitor cells located in the intestinal crypt, a niche that lies at the base of each villus (20, 21) . To address the question of when in the cell cycle critically short telomeres uncap, we studied telomere dysfunction-induced apoptosis in TERT knockout mice. TERT ϩ/Ϫ mice were intercrossed to yield firstgeneration (G1) TERT Ϫ/Ϫ mice, which were viable and lacked telomerase activity, but retained functional telomeres. G1 TERT Ϫ/Ϫ mice were bred to yield G2 TERT Ϫ/Ϫ mice, and this strategy was continued until G5 TERT Ϫ/Ϫ mice were obtained. Cytogenetics and telomere FISH analysis of bone marrow cells showed that telomeres remained functional in TERT ϩ/ϩ mice and G1 TERT Ϫ/Ϫ mice. In contrast, metaphase spreads from G5 TERT Ϫ/Ϫ mice showed a significant increase in chromosome ends lacking detectable telomere signal by FISH (signal-free ends) [supporting information (SI) Fig. 5 ]. To characterize the response to dysfunctional telomeres in TERT Ϫ/Ϫ mice, we assayed apoptosis by TUNEL in gastrointestinal crypts. Apoptotic cells were rare in age-matched TERT ϩ/ϩ and G1 TERT Ϫ/Ϫ intestinal crypts, consistent with preservation of telomere function in early-generation telomerase knockout mice ( Fig. 1 a and  b) (10, 14, 22) . In contrast, critical telomere shortening achieved through successive generations of intercrossing TERT Ϫ/Ϫ mice resulted in a profound increase in apoptosis in the crypts of G5 TERT Ϫ/Ϫ mice (Fig. 1c) . Apoptotic cells were seen only in the proliferating progenitor cell compartments, because TUNELpositive cells were restricted to the population of cells that were Ki-67-positive ( Fig. 1 g-i) . Telomere shortening induced stabilization of p53 protein in crypt progenitor cells of G5 TERT Ϫ/Ϫ mice ( Fig. 1 d-f ), consistent with activation of a p53 DNA damage response by telomere uncapping in late-generation TERT Ϫ/Ϫ cells and similar to results seen in TERC Ϫ/Ϫ mice (11, 23) . Consistent with a DNA damage response in a subset of crypt progenitor cells, strong ␥-H2AX staining was seen only in G5 TERT Ϫ/Ϫ mice ( Fig. 1 j-l) . These data indicate that telomere uncapping induces apoptosis in rapidly dividing epithelial progenitor cells in vivo, suggesting that continual cycling is important for telomere uncapping.
Determining the Percentage of Cells That Require S-Phase Progression
for Telomere Uncapping-Induced Apoptosis. Although short telomeres show an increased probability of uncapping, this uncapping could occur either stochastically in different phases of the cell cycle or in a specific cell cycle phase. For example, progression through S-phase, the period during which telomeres must be replicated and repackaged, could be important for physical uncapping of the telomere end and activation of the apoptotic response. To determine the percentage of apoptotic cells that pass through S-phase, G5 TERT Ϫ/Ϫ mice were pulsed with a single BrdU injection, killed 4 hours later, and analyzed simultaneously for BrdU incorporation and TUNEL by using fluorescent double immunostaining ( Fig. 2 a-d) . Interestingly, a significant percentage of TUNEL-positive cells were also BrdUpositive (Fig. 2d, arrows) . To determine whether overlapping TUNEL and BrdU signals originated within the same cell, we analyzed samples by confocal microscopy. Confocal images showed that the TUNEL signal was distributed in a ring-shaped pattern at the nuclear periphery, a classic pattern in apoptotic cells visualized by confocal imaging (24) . Importantly, BrdU signal was clearly seen within the interior of the TUNEL signal in a subset of apoptotic cells ( Fig. 2 h and i and SI Movie 1). Thus, many cells undergoing apoptosis recently incorporated BrdU before initiation of the apoptotic program.
Of the TUNEL-positive cells, 36.7% showed strong BrdU staining, indicating that they passed through S-phase and became apoptotic during this 4-hour period (Table 1) . However, this is only a lower limit on the percentage of cells that become apoptotic after S-phase, because many of the BrdU-negative apoptotic cells were generated before the labeling period and are cleared gradually from the tissue over time. We reasoned that we could correct for the persistence of these slowly cleared apoptotic cells and accurately determine the percentage of newly generated apoptotic cells that passed through S-phase by constructing a mathematical model.
In constructing the model, we assume that apoptosis in the tissue is in equilibrium, such that the number of apoptotic cells generated during a specific time interval equals the number of apoptotic cells cleared during that interval. This is a reasonable assumption because the intrinsic rate of telomere uncapping will not change over this short period. Under equilibrium conditions, we can calculate the rate of apoptosis from the half-life for clearance of apoptotic fragments, a value that we can measure empirically (see below). We wish to determine what fraction of the apoptotic cells generated during a short time interval passed through S-phase. We therefore define the following two populations of apoptotic cells:
A ϭ A(t) ϭ the total number of apoptotic cells per 100 crypts at time t.
S ϭ S(t) ϭ the number of cells within the apoptotic population A(t) that entered S-phase after time 0 and before time t. S Ͻ A, because S represents a subset of the cells counted in A. We then create a model based on the rates of change for these populations over time, dA/dt and dS/dt:
Eq. 1 describes how A changes over time, with cells produced at rate p and lost at rate cA, where c is the clearance rate constant for apoptotic cells. Eq. 2 describes the rate of change in population S over time, with cells produced at rate kp and lost at rate cS. The constants p and c are the same as in Eq. 1. The constant k represents the fraction of apoptotic cells that were generated during, or shortly after, S phase. We wish to solve for k, and, by definition, 0 Յ k Յ 1. For example, if k ϭ 1, then all epithelial progenitors initiate apoptosis after S-phase entry. Alternatively, if k ϭ 0.5, then one-half of epithelial cells enter apoptosis after S-phase and the remaining half undergo apoptosis in other cell cycle phases. Therefore, determining the value of k will tell us the percentage of gastrointestinal progenitor cells that undergo telomere dysfunction-induced apoptosis after S-phase entry.
We use the differential equations in Eqs. 1 and 2 together with the experimental data above to obtain an estimate of k. Eq. 2 is a separable differential equation, and its solution is:
(see SI Text for details of this calculation). Our experimental data (Table 1) show that 36.7% of apoptotic cells were BrdUpositive at t ϭ 4 h, which is a direct measure of S(t) and can be represented as S(4) ϭ 0.367 ϫ A. Incorporating these empiric data, we thus solve Eq. 3 for k, and substitute t ϭ 4, and S ϭ 0.367
Eq. 4 allows the calculation of k, providing that we know c, the clearance rate constant for apoptotic bodies; and the value of c is related to half-life t 1/2 as c ϭ (ln 2)/t 1/2 . The half-life of apoptotic bodies in small intestinal crypts of wild-type mice treated with DNA-damaging agents has been empirically measured and ranges from t 1/2 ϭ 3.5 h, for apoptosis caused by hydroxyurea treatment, to t 1/2 ϭ 11.8 h, for apoptosis caused by ionizing radiation (25) . Because this range is too large for an accurate measurement of k in our study, we designed an exper- (Fig. 3a) Table 2 ). From these data, we calculated t 1/2 using a standard one-phase exponential decay model, yielding a value of t 1/2 ϭ 5.00 Ϯ 0.68 h (c ϭ 0.139 Ϯ 0.09; r 2 ϭ 0.896) (Fig. 3b) . Interestingly, this value for t 1/2 falls between the previously published values for t 1/2 in gastrointestinal crypts and closer to the value for t 1/2 in mice treated with hydroxyurea (25) .
Apoptosis Induced by Telomere Uncapping Is Coupled to S-Phase in
Progenitor Cells. Having measured the clearance rate c, we can now represent graphically how S(t), the fraction of apoptotic cells whose telomeres uncap during or shortly after S-phase, accumulate over time as a fraction of all apoptotic cells in the population, A (Fig. 4a) . Furthermore, with the measured value of c ϭ 0.139, we can use Eq. 4 to calculate k, which yields k ϭ 86.2 Ϯ 8.8%. These data indicate that 86.2% of gastrointestinal crypt cells passed through S-phase shortly before the initiation of the apoptotic program. Importantly, this value for k markedly exceeds the labeling index of 23%, the percentage of total cells in small-intestine crypts that are labeled with short pulses of BrdU or tritiated thymidine (26, 27) . Thus, the high value for k does not simply reflect the fact that many progenitor cells are actively cycling. If apoptosis were initiated in a cell cycle- Telomere uncapping is linked to S-phase in progenitor cells of late-generation TERT Ϫ/Ϫ mice. (a) Graph depicting the dependence of telomere uncapping-induced apoptosis on S-phase. The number of cells that become apoptotic during or shortly after S-phase as a percentage of the total number of apoptotic cells, S(t)/A, is graphed versus time, based on Eq. 3 and by using our empirically derived values for k and c. Beginning at t ϭ 0, the model depicts the gradual accumulation of cells becoming apoptotic as a result of telomere uncapping in S-phase. At t ϭ 4 h, S(t) ϭ 36.7% (point on graph), representing our empiric measurement using BrdU incorporation. The graph asymptotically approaches 86.2%, our calculated value for k, which represents the percentage of apoptotic cells that die in S-phase or G 2 (dashed red line). (b) A model for telomere uncapping in the cell cycle. Telomeres uncap in late S-phase or in G 2, resulting in either a DNA damage response that signals checkpoints (solid line) or a repair-mediated joining process leading to chromosomal fusion (dashed lines). The damage pathway results in apoptosis in crypt progenitor cells. In human fibroblasts, telomere uncapping may be similar in its cell cycle timing but induces senescence in a subsequent G 1 phase.
independent manner, we would anticipate a value for k much closer to the labeling index of 23%.
Eq. 4 can also be used to predict t 1/2 for any value of k. If we assume that all cells must pass through S-phase before undergoing apoptosis (k ϭ 1), we calculate, using our empiric data, that t 1/2 for clearance of apoptotic cells in TERT Ϫ/Ϫ mice equals 6.06 Ϯ 0.236 h, a value very close to our measured t 1/2 of 5.00 h (see SI Text for details of these calculations) (25) . Taken together, these results show that S-phase progression is a prerequisite for telomere uncapping-induced apoptosis for the vast majority, and perhaps all, gastrointestinal progenitor cells in late-generation TERT Ϫ/Ϫ mice.
Apoptosis Induced by Uncapped Telomeres Does Not Require Mitosis.
Telomere uncapping can induce cellular responses by direct activation of DNA damage response pathways. Alternatively, uncapped telomeres can fuse to yield dicentric chromosomes whose breakage during mitosis may also activate DNA damage responses to induce apoptosis. To understand whether gastrointestinal progenitor cells initiate apoptosis before or after mitosis, we performed our BrdU and TUNEL analysis on mice treated with mitotic inhibitor colcemid. We used a colcemid protocol previously shown to block all gastrointestinal (GI) progenitor cells in vivo in early mitosis (28, 29) . Consistent with these data, we found that the prevalence of mitotic figures was increased 2-fold in mice treated with colcemid for 4 hours, compared with untreated controls (data not shown). Analysis of G5 TERT Ϫ/Ϫ mice treated with colcemid and injected with BrdU revealed that 43.6% of apoptotic cells were BrdU-positive (Table  1 and Fig. 2 e-g ), results that were in close agreement with those derived from G5 TERT Ϫ/Ϫ mice that did not receive colcemid. These findings show that mitotic blockade had little effect on apoptosis, consistent with previous results in telomerase knockout lymphocytes cultured in vitro (30) . Using this value of 43.6% for the percentage of apoptotic cells that were BrdU-positive in a setting of mitotic inhibition, we can reformulate S as S(4) ϭ 0.436 ϫ A and rederive Eq. 4 as above. Solving Eq. 4 with c ϭ 0.139, we find that, for mice treated with colcemid, k ϭ 1.02. These data indicate that, in the presence of colcemid, 100% of gastrointestinal progenitor cells undergo telomere uncappinginduced apoptosis shortly after S-phase but before mitosis. We conclude that telomere uncapping in telomerase-deficient epithelial cells occurs in late S-phase or in G 2 , a period consistent with the timing of telomere replication. The inability to repackage these telomere ends in a protected conformation induces apoptosis directly, without requiring progression through mitosis and is therefore independent of a fusion-bridge breakage mechanism (Fig. 4b) .
Discussion Telomere Uncapping Is a Stereotyped Process Linked to Cell Cycle
Progression. The probability that a telomere can switch from a protected, capped state to a deprotected, uncapped one increases as the telomeric repeats become very short, ultimately activating a DNA damage response causing cell cycle arrest or apoptosis (3) . These responses can contribute to certain aspects of aging, can dramatically impair stem cell renewal, and can destabilize chromosomes, promoting tumorigenesis. To understand the relationship between uncapping and cell cycle, we analyzed epithelial progenitor cells in TERT Ϫ/Ϫ mice in vivo, which, instead of senescence, respond to telomere uncapping through apoptosis. By labeling S-phase cells with a brief pulse of BrdU, we tracked the fate of these cells that passed through S-phase and found that many apoptotic cells (37%) had incorporated BrdU, even during this short period. We reasoned that the true percentage of cells that initiate apoptosis during or shortly after S-phase was substantially higher than 37% because most of the BrdU-negative apoptotic cells were generated before the BrdU pulse and are cleared from the tissue gradually over time.
To correct for the persistence of apoptotic cells in the tissue, we developed a mathematical model based on the fact that apoptosis in the small intestine of TERT Ϫ/Ϫ mice is in equilibrium, indicating that the production rate of apoptotic cells must equal the clearance rate. We empirically measured the half-life and clearance rate of apoptotic cells in TERT Ϫ/Ϫ mice, allowing us to finalize the model and determine the relationship between S-phase and apoptotic entry. This approach allowed us to define a population of cells that undergo apoptosis during S-phase and revealed the kinetics with which these S-phase cells become apoptotic (Fig. 4a) . Using our empiric data and this mathematical model, we calculated the value of the variable k, representing the fraction of apoptotic cells undergoing apoptosis during or shortly after S-phase to be 86 Ϯ 8.8%. Together, these data show that apoptosis triggered by telomere uncapping is a stereotyped, cell cycle-dependent process, rather than a stochastic one resulting in uncapping in different cell cycle phases.
A Model for Synchronized Uncapping with Replication of Critically
Short Telomeres. We propose that critically short telomeres are especially vulnerable to uncapping during telomere replication for two reasons. First, replication of both the leading and lagging strands requires that the three-dimensional structure of the telomere is temporarily disrupted by the passage of replication forks. Second, loss of telomere sequences because of the endreplication problem occurs precisely during this phase of telomere replication at the lagging strand. In addition, telomere ends are likely subject to exonucleolytic attack, which may further exacerbate the instability of critically short telomeres (31) . Unlike chromosome ends with sufficient reserves of telomere repeats, a critically short telomere may not support the formation of a stable conformation after replication. Uncapping of telomeres in this manner would activate the DNA damage machinery and a corresponding cellular response, consistent with the stereotypic apoptotic response seen in mouse gastrointestinal tract.
These data fit with a large body of evidence linking telomere replication to late S phase or G 2 in diverse species (32) (33) (34) . In addition, components of Mre11-Rad50-Nbs1, a DNA repair complex, were shown to transiently associate with telomeres during S phase in both yeast and human cells, suggesting a role for these proteins in telomere replication or repair (35, 36) . Recently, telomeres were shown to elicit a transient DNA damage response during the G 2 phase of the cell cycle. During this stage of replication, telomeres recruit ␥-H2AX, 53BP1, and phospho-ATM, but these damage complexes rapidly dissipate from telomeres, presumably as telomeres become properly packaged (37) . Perhaps, these damage foci persist at an uncapped telomere, initiating a full-fledged DNA damage response. The ensuing apoptosis would occur in a synchronized fashion during or shortly after S-phase, consistent with our findings.
Telomere uncapping has been extensively studied by interfering with TRF2 function, which, in TRF2 conditional knockout mice, causes rapid uncapping in quiescent hepatocytes (19) . In addition, induction of apoptosis by dominant-negative TRF2 in proliferating human T cells did not require S-phase entry (38) . Thus, telomere uncapping per se does not require S-phase when telomere structure is perturbed by removal of critical telomerebinding proteins. The contrast between these results and ours in telomerase knockout mice likely reflects differences in the nature of the stimulus that causes uncapping. Our data suggest that telomere uncapping because of insufficient telomerase occurs specifically in S-phase, as a subset of the shortest telomeres can no longer be maintained in a protected conformation.
Implications for Telomere Uncapping at Replicative Senescence.
These data suggest that the timing of telomere uncapping in cells undergoing apoptosis in telomerase knockout mice and human fibroblasts at replicative senescence in human fibroblasts may be similar. Telomere uncapping in both cases may occur in an S-phase-dependent fashion, but the principal difference may be in the cellular response. Whereas mouse gastrointestinal progenitors possess a potent apoptotic response to telomere uncapping and other DNA damage signals, fibroblasts lack such an apoptotic response, instead undergoing cell cycle arrest when confronted with DNA damage. In the absence of a strong apoptotic response, telomere uncapping in late S-phase in human fibroblasts may go incompletely recognized until the next G 1 phase, where activation of p53 and Rb pathways enforce cell cycle arrest and senescence (Fig. 4b) . Alternatively, telomere uncapping in S-phase could activate an S-phase checkpoint, adaptation to which allows eventual progression to G 1 , where the terminal senescence program is revealed (39, 40) . Together, these findings provide insight into the mechanism of telomere dysfunction, linking the uncapping response to S-phase and to telomere replication.
Materials and Methods
Mice. TERT knockout mice were generated by gene targeting in embryonic stem cells as described (S.R. and S.E.A., unpublished work). All mice were maintained on a mixed genetic background, 50:50 C57BL/6:129S4. TERT ϩ/Ϫ mice were intercrossed to yield G1 TERT Ϫ/Ϫ mice, which, in turn, were intercrossed to create G2 TERT Ϫ/Ϫ mice and so on, until G5 TERT Ϫ/Ϫ mice were derived. Cousin mating schemes were used to prevent the generation of substrains (10) . All mice were treated in accordance with Association for Assessment and Accreditation of Laboratory Animal Care-approved guidelines at Stanford University.
Kinetic Analyses Using BrdU Incorporation. BrdU (0.1 mg/g of body weight) was injected i.p. To assess rates of BrdU injection during apoptosis, mice were killed 4 h after injection. Three mice were analyzed per genotype, and GI tracts were cleaned and fixed immediately after sacrifice. To block mitosis, mice were injected with colcemid (1 g/g of body weight) and BrdU simultaneously and then analyzed at 4 h. For half-life measurements, G5 TERT Ϫ/Ϫ mice in groups of three were injected with BrdU and chased for a total of 4, 6, 8, 10, and 12 h and then analyzed as above.
Immunohistochemistry of GI Crypts. The entire small intestine was opened longitudinally and rolled into a Swiss roll with the luminal side facing outward and then fixed in 10% formalin. TUNEL was performed on paraffin-embedded 5-m tissue sections by using an Apoptag kit according to the manufacturer's instructions (Chemicon, Temecula, CA). TUNEL/BrdU double immunostaining was performed sequentially on the same tissue section. Each section was first processed for TUNEL by using a fluorescein-conjugated secondary antibody (Chemicon), followed by incubation with a rat monoclonal primary antibody against BrdU (Abcam, Cambridge, MA) and anti-rat cy-3 secondary antibody. The following antibodies were used for immunohistochemistry: p53, CM5 rabbit polyclonal antibody (Novocastra, Newcastle-upon-Tyne, U.K.); Ki-67, mouse anti-human monoclonal antibody (BD Pharmingen, Franklin Lakes, NJ); and ␥H2AX, mouse monoclonal antibody (Upstate Biotechnology, Lake Placid, NY).
Mathematical Calculations and Graphs. One-phase exponential decay was fit to data from SI Table 2 to generate the apoptotic cell half-life analysis in Fig. 3b . Eq. 3 was used together with our empiric data to generate the model to describe the relationship between S-phase and apoptosis in Fig. 4a . Both graphs were generated by using Mathematica 5.2 (Wolfram Research, Champaign, IL).
